Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Eastern Exchange launches IPO infrastructure

1/24/25 MOEX

TGC-1 generation remained at the same level as last year

1/24/25 TGKA

LSR reported a decline in sales

1/24/25 LSRG

Fesco increased transportation between Vladivostok and China

1/24/25 FESH

Fix Price transferred its business to a Russian JSC

1/24/25 FIXP

T-Bank and Rosbank's RAS profit in 2024 increased by 42%

1/24/25 T

Key modules for Arctic LNG-2 returned to China

1/23/25 NVTK

Softline repaid its debt to BERKS

1/23/25 SOFL

IT distributor BERKS claims ₽1 billion of debt from Softline

1/23/25 SOFL

Henderson reopened a salon in Taganrog

1/23/25 HNFG